Stephanie Lauren Vanschaick, DPT | |
77 Medford Ave, Patchogue, NY 11772-1281 | |
(631) 758-1910 | |
(631) 758-1984 |
Full Name | Stephanie Lauren Vanschaick |
---|---|
Gender | Female |
Speciality | Physical Therapy |
Experience | 6 Years |
Location | 77 Medford Ave, Patchogue, New York |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1083195895 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | 043431 (New York) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
New York University | 1355232422 | 4431 |
News Archive
The usage of e-cigarettes containing nicotine has a significant impact on vascular functions claims new study.
The results of a new research showed that many of the genes that are expressed by microglia are different between humans and mice, which are frequently used as animal models in research on Alzheimer's disease and other neurodegenerative disorders.
In just the past few years, researchers have found a way to use a naturally occurring bacterial system known as CRISPR/Cas9 to inactivate or correct specific genes in any organism. CRISPR/Cas9 gene editing activity runs continuously, though, leading to risk of additional editing at unwanted sites. Now, researchers at University of California, San Diego School of Medicine, Ludwig Cancer Research and Isis Pharmaceuticals demonstrate a commercially feasible way to use RNA to turn the CRISPR-Cas9 system on and off as desired - permanently editing a gene, but only temporarily activating CRISPR-Cas9.
Vascular interventions performed in pediatrics require imaging equipment specially designed for this setting. During the Pediatric and Adult Interventional Cardiac Symposium (PICS-AICS), July 24-27, 2011 in Boston, three leading pediatric cardiac hospitals will perform live cases with Toshiba America Medical Systems, Inc.'s Infinix™ CF-i bi-plane cardiovascular systems.
› Verified 9 days ago
Provider Name | South Shore Neurologic Associates, Pc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1083782460 PECOS PAC ID: 5092602110 Enrollment ID: O20040303000492 |
News Archive
The usage of e-cigarettes containing nicotine has a significant impact on vascular functions claims new study.
The results of a new research showed that many of the genes that are expressed by microglia are different between humans and mice, which are frequently used as animal models in research on Alzheimer's disease and other neurodegenerative disorders.
In just the past few years, researchers have found a way to use a naturally occurring bacterial system known as CRISPR/Cas9 to inactivate or correct specific genes in any organism. CRISPR/Cas9 gene editing activity runs continuously, though, leading to risk of additional editing at unwanted sites. Now, researchers at University of California, San Diego School of Medicine, Ludwig Cancer Research and Isis Pharmaceuticals demonstrate a commercially feasible way to use RNA to turn the CRISPR-Cas9 system on and off as desired - permanently editing a gene, but only temporarily activating CRISPR-Cas9.
Vascular interventions performed in pediatrics require imaging equipment specially designed for this setting. During the Pediatric and Adult Interventional Cardiac Symposium (PICS-AICS), July 24-27, 2011 in Boston, three leading pediatric cardiac hospitals will perform live cases with Toshiba America Medical Systems, Inc.'s Infinix™ CF-i bi-plane cardiovascular systems.
› Verified 9 days ago
Provider Name | New York University |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1285826438 PECOS PAC ID: 1355232422 Enrollment ID: O20081202000185 |
News Archive
The usage of e-cigarettes containing nicotine has a significant impact on vascular functions claims new study.
The results of a new research showed that many of the genes that are expressed by microglia are different between humans and mice, which are frequently used as animal models in research on Alzheimer's disease and other neurodegenerative disorders.
In just the past few years, researchers have found a way to use a naturally occurring bacterial system known as CRISPR/Cas9 to inactivate or correct specific genes in any organism. CRISPR/Cas9 gene editing activity runs continuously, though, leading to risk of additional editing at unwanted sites. Now, researchers at University of California, San Diego School of Medicine, Ludwig Cancer Research and Isis Pharmaceuticals demonstrate a commercially feasible way to use RNA to turn the CRISPR-Cas9 system on and off as desired - permanently editing a gene, but only temporarily activating CRISPR-Cas9.
Vascular interventions performed in pediatrics require imaging equipment specially designed for this setting. During the Pediatric and Adult Interventional Cardiac Symposium (PICS-AICS), July 24-27, 2011 in Boston, three leading pediatric cardiac hospitals will perform live cases with Toshiba America Medical Systems, Inc.'s Infinix™ CF-i bi-plane cardiovascular systems.
› Verified 9 days ago
Provider Name | New York University |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1285826438 PECOS PAC ID: 1355232422 Enrollment ID: O20090822000026 |
News Archive
The usage of e-cigarettes containing nicotine has a significant impact on vascular functions claims new study.
The results of a new research showed that many of the genes that are expressed by microglia are different between humans and mice, which are frequently used as animal models in research on Alzheimer's disease and other neurodegenerative disorders.
In just the past few years, researchers have found a way to use a naturally occurring bacterial system known as CRISPR/Cas9 to inactivate or correct specific genes in any organism. CRISPR/Cas9 gene editing activity runs continuously, though, leading to risk of additional editing at unwanted sites. Now, researchers at University of California, San Diego School of Medicine, Ludwig Cancer Research and Isis Pharmaceuticals demonstrate a commercially feasible way to use RNA to turn the CRISPR-Cas9 system on and off as desired - permanently editing a gene, but only temporarily activating CRISPR-Cas9.
Vascular interventions performed in pediatrics require imaging equipment specially designed for this setting. During the Pediatric and Adult Interventional Cardiac Symposium (PICS-AICS), July 24-27, 2011 in Boston, three leading pediatric cardiac hospitals will perform live cases with Toshiba America Medical Systems, Inc.'s Infinix™ CF-i bi-plane cardiovascular systems.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Stephanie Lauren Vanschaick, DPT 712 Main St, Islip, NY 11751-3620 Ph: (631) 666-3951 | Stephanie Lauren Vanschaick, DPT 77 Medford Ave, Patchogue, NY 11772-1281 Ph: (631) 758-1910 |
News Archive
The usage of e-cigarettes containing nicotine has a significant impact on vascular functions claims new study.
The results of a new research showed that many of the genes that are expressed by microglia are different between humans and mice, which are frequently used as animal models in research on Alzheimer's disease and other neurodegenerative disorders.
In just the past few years, researchers have found a way to use a naturally occurring bacterial system known as CRISPR/Cas9 to inactivate or correct specific genes in any organism. CRISPR/Cas9 gene editing activity runs continuously, though, leading to risk of additional editing at unwanted sites. Now, researchers at University of California, San Diego School of Medicine, Ludwig Cancer Research and Isis Pharmaceuticals demonstrate a commercially feasible way to use RNA to turn the CRISPR-Cas9 system on and off as desired - permanently editing a gene, but only temporarily activating CRISPR-Cas9.
Vascular interventions performed in pediatrics require imaging equipment specially designed for this setting. During the Pediatric and Adult Interventional Cardiac Symposium (PICS-AICS), July 24-27, 2011 in Boston, three leading pediatric cardiac hospitals will perform live cases with Toshiba America Medical Systems, Inc.'s Infinix™ CF-i bi-plane cardiovascular systems.
› Verified 9 days ago
Ronald Amaya Lopez, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 322 W Main St, Patchogue, NY 11772 Phone: 631-228-4977 | |
Sungguk Bae, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 21 Cleveland St, Patchogue, NY 11772 Phone: 631-569-9373 | |
Nicole Marie Divirgilio, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 77 Route 112 Ste F, Patchogue, NY 11772 Phone: 631-207-2370 | |
John Lowe Wilson, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 25 Theresa Ct, Patchogue, NY 11772 Phone: 631-730-3326 | |
Danielle M Bousquet, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 77 Medford Ave, Patchogue, NY 11772 Phone: 631-758-1910 | |
Kathleen Alyssa Bailey, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 322 W Main St, Patchogue, NY 11772 Phone: 631-228-4977 |